Results 231 to 240 of about 644,957 (254)

INTERMITTENT DOSING OF MDM2 INHIBITOR

2015
FERRETTI STEPHANE, JEAY SEBASTIEN
openaire   +3 more sources

The central valine concept provides an entry in a new class of non peptide inhibitors of the p53–MDM2 interaction

Bioorganic and Medicinal Chemistry Letters, 2012
Patrick Chene, Joerg Kallen, Pascal Furet   +2 more
exaly  

Discovery of Dual Inhibitors of MDM2 and XIAP for Cancer Treatment

Cancer Cell, 2016
Yuhong Du, Sheng Zhou, Haian Fu
exaly  

Modulation of the p53/MDM2 interplay by HAUSP inhibitors

Journal of Molecular Cell Biology, 2017
Omid Tavana, Wei Gu
exaly  

Design, synthesis and biological evaluation of novel potent MDM2/p53 small-molecule inhibitors

Bioorganic and Medicinal Chemistry Letters, 2015
Elena Beloglazkina, Aleksei Machulkin, Dmitry Skvortsov   +2 more
exaly  

Design, Synthesis and Biological Evaluation of Sulfamide and Triazole Benzodiazepines as Novel p53-MDM2 Inhibitors

International Journal of Molecular Sciences, 2014
Zhenyuan Miao, Chunquan Sheng, Chunlin Zhuang   +2 more
exaly  

Inhibitors of the interaction between MDM2 and P53

2010
PONCELET VIRGINIE SOPHIE, COUPA SOPHIE, STORCK PIERRE-HENRI, SCHOENTJES BRUNO   +3 more
openaire   +6 more sources

Targeting p53-MDM2 Interaction Using Small Molecule Inhibitors and the Challenges Needed to be Addressed

Current Drug Targets, 2019
Maryam Zanjirband, Soheila Rahgozar
exaly  

Discovery of dihydroisoquinolinone derivatives as novel inhibitors of the p53–MDM2 interaction with a distinct binding mode

Bioorganic and Medicinal Chemistry Letters, 2015
Sébastien Jeay, Patrick Chene, Joerg Kallen   +2 more
exaly  

METHODS OF IDENTIFYING AND USING MDM2 INHIBITORS

2013
KORNBLUTH SALLY, KUROKAWA MANABU, SPECTOR NEIL, DEWHIRST MARK   +3 more
openaire   +5 more sources